Mesoblast Limited vs Peak Processing Limited
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
Market cap history
● Mesoblast Limited● Peak Processing Limited
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Mesoblast Limited MSB.AX | Peak Processing Limited PKP.AX |
|---|---|---|
| Profile | ||
| Country | 🇦🇺 Australia | 🇦🇺 Australia |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | — |
| Founded | — | — |
| Size | ||
| Revenue | $17 M | — |
| Net income | $-102 M | — |
| Profitability | ||
| Gross margin | 70.2% | — |
| Net margin | -593.8% | — |
| Return on equity | -18.9% | — |
| Growth | ||
| Revenue growth | 191.5% | — |
| Revenue growth, 3 years a year | 19.0% | — |
| Financial strength | ||
| Debt to equity | 0.1× | — |
| Cash | ||
| Free cash flow margin | -294.4% | — |
| Strength scores | ||
| Piotroski F-score | 5 of 9 | — |
| Altman Z-score zone | — | — |
| Data as of | Market cap Jan 2024; ratios FY2025 | Market cap — |